![Anthony Man](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. Anthony Man, MD, is an Independent Member-Supervisory Board at MediGene AG.
He is on the Board of Directors at MediGene AG.
Dr. Man was previously employed as a Global Head-Clinical Development by Novartis Pharma AG and a Chief Executive Officer by Basilea Pharmaceutica AG.
Aktiva positioner av Anthony Man
| Företag | Position | Start |
|---|---|---|
| MEDIGENE AG | Direktör/Styrelseledamot | 2020-12-16 |
Tidigare kända positioner av Anthony Man
| Företag | Position | Slut |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Företagsledare/Principal | 2021-08-01 |
| BASILEA PHARMACEUTICA AG | President | 2012-12-31 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
46
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
